Gannett to Participate at the 20th Annual Needham Technology, Media, & Consumer Conference

Gannett to Participate at the 20th Annual Needham Technology, Media, & Consumer Conference

NEW YORK, NY–(BUSINESS WIRE)–
Gannett Co., Inc. (“Gannett”, “we”, “our”, or the “Company”) (NYSE: GCI) today announced that its Chief Financial Officer, Trisha Gosser, will participate virtually at the following conference:

Needham 20th Annual Technology, Media & Consumer Conference

Monday, May 12, 2025

One-on-one investor meetings throughout the day

About Gannett

Gannett Co., Inc. (NYSE: GCI) is a diversified media company with expansive reach at the national and local level dedicated to empowering and enriching communities. We seek to inspire, inform, and connect audiences as a sustainable, growth focused media and digital marketing solutions company. We endeavor to deliver essential content, marketing solutions, and experiences for curated audiences, advertisers, consumers, and stakeholders by leveraging our diverse teams and suite of products to enrich the local communities and businesses we serve. Our current portfolio of trusted media brands includes the USA TODAY NETWORK, comprised of the national publication, USA TODAY, and local media organizations in the United States, and Newsquest, a wholly-owned subsidiary operating in the United Kingdom. Our digital marketing solutions brand, LocaliQ, uses innovation and software to enable small and medium-sized businesses to grow, and USA TODAY NETWORK Ventures, our events division, creates impactful consumer engagements, promotions, and races.

Our website address is www.gannett.com. We use our website as a channel of distribution for important company information, including press releases and other news and presentations, which is accessible on the Investor Relations and News and Events subpages of our website.

For investor inquiries, contact:

Matt Esposito

Investor Relations

703-854-3000

[email protected]

For media inquiries, contact:

Lark-Marie Anton

Corporate Communications

646-906-4087

[email protected]

KEYWORDS: United States North America New York Virginia

INDUSTRY KEYWORDS: Digital Marketing Other Communications Publishing Media Marketing Content Marketing Advertising Communications

MEDIA:

Logo
Logo

Signet Jewelers Announces Timing of Fiscal 2026 First Quarter Earnings Release and Conference Call

Signet Jewelers Announces Timing of Fiscal 2026 First Quarter Earnings Release and Conference Call

HAMILTON, Bermuda–(BUSINESS WIRE)–
Signet Jewelers Limited (NYSE: SIG) intends to announce its first quarter results at approximately 7:00 a.m. ET on Tuesday, June 3, 2025.

On that date there will be a conference call at 8:30 a.m. ET and a simultaneous audio webcast available at www.signetjewelers.com.

The call details are:

Toll Free – North America (+1) 800 549 8228

International All Other Location: (Toll – Local – New York) – (+1) 646 564 2877

Conference ID 90783

Registration for the listen-only webcast is available at the following link:

https://events.q4inc.com/attendee/390899932

About Signet:

Signet Jewelers Limited is the world’s largest retailer of diamond jewelry. As a Purpose-driven and sustainability-focused company, Signet is a participant in the United Nations Global Compact and adheres to its principles-based approach to responsible business. Signet operates eCommerce sites and approximately 2,700 stores under the name brands KAY Jewelers, Zales, Jared, Banter by Piercing Pagoda, Diamonds Direct, Blue Nile, James Allen, Rocksbox, Peoples Jewellers, H.Samuel, and Ernest Jones. Our sales derive from the retailing of jewelry, watches, and associated services. Further information on Signet is available at www.signetjewelers.com. See also www.kay.com, www.zales.com, www.jared.com, www.banter.com, www.diamondsdirect.com, www.bluenile.com, www.jamesallen.com, www.rocksbox.com, www.peoplesjewellers.com, www.hsamuel.co.uk, www.ernestjones.co.uk.

Investors:

Rob Ballew

SVP, Investor Relations

+1 336 202 1203

[email protected]

Investor Relations

[email protected]

Media:

Colleen Rooney

Chief Communications & ESG Officer

+1 330 668 5932

[email protected]

KEYWORDS: Caribbean United States Bermuda North America Ohio

INDUSTRY KEYWORDS: Fashion Online Retail Retail Luxury Bridal Specialty

MEDIA:

Natural Grocers® Celebrates Moms, May and the Moments That Matter

PR Newswire

Exclusive Mother’s Day offers, gifts and surprises May 9–11, at all 169 Natural Grocers® stores


LAKEWOOD, Colo.
, May 6, 2025 /PRNewswire/ — Natural Grocers®, the nation’s largest family-operated organic and natural grocery retailer, is celebrating the mothers and maternal figures who make life a little brighter with a monthlong celebration. The company will offer exclusive discounts, free gifts and festive surprises starting Mother’s Day weekend, May 9–11, and continuing through the end of May.

Shop May 9-11 for exclusive Mother’s Day deals at Natural Grocers & celebrate the people who nourish & inspire others.

With deals on natural body care, indulgent treats, giftable goods and more, shoppers can find meaningful ways to show appreciation—without breaking the bank. Customers will also enjoy giveaways and cheerful in-store touches during the holiday weekend.

“Moms give so much of themselves to the people and communities they care for,” said Raquel Isely, vice president of marketing for Natural Grocers. “This celebration is one way we’re helping our customers say thank you—with thoughtful gifts, delicious and easy recipes, healthy treats and meaningful moments.”

ROOTED IN CARE
Natural Grocers has honored moms since its beginning in 1955. Co-founder Margaret Isely—a wellness pioneer and a mother herself, helped build the company around the idea that everyone should have access to affordable nutrition and a healthy environment. Her legacy has continued for nearly 70 years through the company’s Five Founding Principles, which empower communities with free nutrition education, premium-quality organic and natural products at its Always AffordableSM prices and world-class customer service from its good4uSM Crew.

CELEBRATE THE ONES WHO NURTURE
With 169 stores in 21 states, Natural Grocers invites shoppers to stop by this May to celebrate the people who nourish and inspire others, whether by raising children, mentoring, caregiving or simply showing up with love.


May 9-May 30:
 Save on groceries, gifts, and “Count the Combs” for a chance to win big!


  • Enjoy discounts up to 43% off
     the Company’s Always Affordable prices on customer favorites, great for seasonal celebrations like select Santa Cruz Organic® Limeade and Lemonades (32 oz./$2.79), Frontera Foods® Salsas (16 oz./$3.79) and Late July® Boldly Flavored Tortilla Chips (7.8 oz./$3.59).[i]

  • Body Care & Beauty Bonanza
    : Stock up or find the perfect gift at up to 25% off during Natural Grocers’ annual Body Care & Beauty Bonanza, including sales on products from the new luxury, plant-based Natural Grocers® Brand Skincare Line, all Weleda Skin Food products (25% off), all My Chelle® products (20% off) and select Zum® Lotions (15% off).[i] Additionally, the first 50 customers at each store on Friday, May 9th, will receive a free beauty bag and a Natural Grocers Brand Bath Bomb.[ii]
  • Win a $500 Natural Grocers Gift Card! Count all the mini-comb illustrations in the May edition of the Natural Grocers good4u Health Hotline® Magazine (Vol. 94) and enter to win.[iii]


May 9-11:
 Shoppers can enjoy special Mother’s Day Deals, with up to 32% off select items, making it easy to treat mom to something thoughtful without stretching the budget.[iv] 

  • All Maggie’s Organics® socks (30% off). 
  • Pacha Soap Company® Signature Candles, Spring Scents (7 oz./$14.99)
  • Zum Bar Soaps (3 oz./$4.29)
  • Honey Mama’s® Cocoa Truffle Bars ($3.79 ea.).

{N}POWER
®
MEMBERSHIP PERKS
Members of {N}power*, Natural Grocers’ free member rewards program, will have access to additional promotions throughout the month, including:

  • May 9-11: {N}power members can enjoy a coffee pep in their steps, with a buy one, get one 50% off Natural Grocers Brand Organic Coffee Products (offer autoloaded to {N}power accounts).[v]
  • May 9-11: Clip coupon for 25% off select kitchen accessories. Look for the click-to-load coupon on May 9 through {N}power email or the Natural Grocers mobile app![vi]
  • May 9-11: {N}power members can enjoy a special offer of 25% off their entire body care and beauty purchase when they clip and save – or rather “click and save” on May 9, through their {N}power email or the Natural Grocers mobile app.[vii]
  • May 9-30: {N}power members who spend over $50 on body care and beauty products will automatically be entered to win a beauty gift basket (valued at over $300) and a $100 Natural Grocers gift card.[viii]

  • May 11:
     {N}power members will receive a FREE 3-ounce Theo® Chocolate Bar. Limit 1 per {N}power account, while supplies last.[ix]
  • May 1-31: In honor of Women’s Health Month, {N}power members who buy any two KAL® products will be automatically entered for a chance to win wellness gifts that fuel good feelings, including an Oura Ring(Gen 4),On Cloud Shoes or a $250lululemon gift card.[x]
  • Through June 30: {N}power members can feed mom and the family in a hearty, affordable fashion, with a Natural Grocers good4u® Meal Deal. Feed up to four for under $16 with a hearty, delicious Mother’s Day Oatmeal Brunch. Gluten-free and vegan options available, under $18.[xi]
  • Click here for all current {N}power Meal Deals from Natural Grocers.

*Not an {N}power member? Not a problem! Signing up is quick and easy. Visit: www.naturalgrocers.com/npower and sign up today.

WHIP UP SOMETHING WONDERFUL FOR MOM
Natural Grocers makes it easy to celebrate with love—and a great meal. Whether you’re planning breakfast in bed, a sunny spring brunch, or a cozy dinner, the Nutrition Education team has curated a fresh batch of recipes that are simple, nourishing and full of seasonal flavor.

GIFT OF NUTRITIONAL EDUCATION + $5 COUPON
Finally, for those looking for one more gift idea for mom, (or themselves) Natural Grocers invites its customers to book a FREE, one-hour in-person, Nutritional Health Coaching session or FREE, 30-minute Personalized Shopping Experience and earn a $5 Natural Grocers coupon.[xii]

ABOUT NATURAL GROCERS BY VITAMIN COTTAGE
Founded in 1955, Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is an expanding specialty retailer of natural and organic groceries, body care products, and dietary supplements. The grocery products sold by Natural Grocers must meet strict quality guidelines and may not contain artificial flavors, preservatives, or sweeteners (as defined by its standards), synthetic colors, or partially hydrogenated or hydrogenated oils. The Company sells only USDA-certified organic produce and exclusively pasture-raised, non-confinement dairy products, and free-range eggs. Natural Grocers’ flexible smaller-store format allows it to offer affordable prices in a shopper-friendly, clean, and convenient retail environment. The Company also provides extensive free science-based Nutrition Education programs to help customers and Crew make informed health and nutrition choices. Natural Grocers is committed to its 5 Founding Principles—including its “Commitment to Community” and “Commitment to Crew”. In fiscal year 2024, the Company invested more than $15 million in incremental compensation and discretionary payments for Crew. Headquartered in the Union Square neighborhood of Lakewood, CO, Natural Grocers has 169 stores in 21 states. Visit www.naturalgrocers.com for more information and store locations. 

[i] Unless otherwise noted, offers are available only from 5/9/25 to 5/30/25 and are redeemable only for in-store customer purchases at participating stores. Quantity limited to stock on hand, no rainchecks. Unless otherwise noted, all discounts are on regular prices, cannot be redeemed for store credit or cash, or combined with other offers. Pricing excludes taxes and is subject to change without notice. Natural Grocers reserves the right to correct errors. Void where prohibited by law.

[ii] Valid 5/9/2025 only to the first 50 customers at participating stores. Limit 1 per in-store customer. Limited to stock on hand; no rainchecks.

[iii] NO PURCHASE NECESSARY. A PURCHASE WILL NOT INCREASE YOUR CHANCES OF WINNING. Open only to legal residents of the following states who are at least 18 years old at the time of entry: Arizona, Arkansas, Colorado, Idaho, Iowa, Kansas, Louisiana, Minnesota, Missouri, Montana, Nebraska, Nevada, New Mexico, North Dakota, Oklahoma, Oregon, South Dakota, Texas, Utah, Washington and Wyoming (each, an “Eligible State”). Void where prohibited by law. Natural Grocers employees, including members of their households, are not eligible for this offer. Sweepstakes starts on 5/9/2025 and ends on 5/30/2025. For official rules and complete details, visit: www.naturalgrocers.com/sweepstakes. Sponsor: Vitamin Cottage Natural Food Markets, Inc.

[iv] Offers are available 5/9/2025 through 5/11/2025 for in-store purchases at participating Natural Grocers stores. Quantity limited to stock on hand; no rainchecks. We reserve the right to correct errors. Void where prohibited by law.

[v] Offers valid for {N}power members and redeemable only for in-store customer purchases. Buy one Natural Grocers Brand coffee, get one 50% off coupon is autoloaded to {N}power member account. Quantity limited to stock on hand; no rain checks. Natural Grocers reserves the right to correct errors. Void where prohibited by law. {N}power offers available only to registered members and are subject to program terms and conditions available at www.naturalgrocers.com/terms.

[vi] Offers valid for {N}power members and redeemable only for in-store customer purchases. Click to load 25% off kitchen accessories to your account from the Natural Grocers mobile app or online dashboard. Quantity limited to stock on hand; no rain checks. Natural Grocers reserves the right to correct errors. Void where prohibited by law. {N}power offers available only to registered members and are subject to program terms and conditions available at www.naturalgrocers.com/terms.

[vii] Valid May 9-11, 2025 for {N}power members only. 25% discounts will be applied to the product’s regular, non-discounted price. To load the offer, you must load the offers from the Natural Grocers Mobile App or online dashboard before shopping. Valid for in-store customer purchases only; be sure to present your phone number at checkout to redeem your discount. Natural Grocers employees, including members of their household, are not eligible. 

[viii] NO PURCHASE NECESSARY. A PURCHASE WILL NOT INCREASE YOUR CHANCES OF WINNING. Open only to legal residents of the following states who are at least 18 years old at the time of entry: Arizona, Arkansas, Colorado, Idaho, Iowa, Kansas, Louisiana, Minnesota, Missouri, Montana, Nebraska, Nevada, New Mexico, North Dakota, Oklahoma, Oregon, South Dakota, Texas, Utah, Washington and Wyoming (each, an “Eligible State”). Must be an {N}power member to enter. Void where prohibited by law. Natural Grocers employees, including members of their households, are not eligible for this offer. Sweepstakes starts on 5/9/2025 and ends on 5/30/2025. For official rules, complete details and alternative method of entry, visit: www.naturalgrocers.com/sweepstakes. Sponsor: Vitamin Cottage Natural Food Markets, Inc.

[ix] Free Theo Chocolate Bar offer is available only to registered {N}power members at participating Natural Grocers stores on 5/11/2025 only. Limit one per {N}power customer. 3 OZ. Organic Chocolate Bar. Excludes 1.7 OZ. and 2.8 OZ. bars. Offer is autoloaded to accounts. Bring chocolate bar to the register to redeem. Quantity limited to stock on hand; no rainchecks.

[x] NO PURCHASE NECESSARY. A PURCHASE WILL NOT INCREASE YOUR CHANCES OF WINNING. Open only to legal residents of the following states who are at least 18 years old at the time of entry: Arizona, Arkansas, Colorado, Idaho, Iowa, Kansas, Louisiana, Minnesota, Missouri, Montana, Nebraska, Nevada, New Mexico, North Dakota, Oklahoma, Oregon, South Dakota, Texas, Utah, Washington and Wyoming (each, an “Eligible State”). Must be an {N}power member to enter. Void where prohibited by law. Sweepstakes starts on 5/1/2025 and ends on 5/31/2025. Two total prize winners will be selected from all eligible entries. For official rules, complete details and alternative method of entry, visit: www.naturalgrocers.com/sweepstakes. Sponsor: Vitamin Cottage Natural Food Markets, Inc.

[xi] THIS OFFER IS AVAILABLE ONLY TO REGISTERED {N}POWER MEMBERS. Must enter phone number associated with {N}power account at checkout to redeem. Offer ends June 30, 2025 and is redeemable only for in-store purchases at participating Natural Grocers stores. Pricing subject to change without notice. Quantity limited to stock on hand; no rain checks. We reserve the right to correct errors.

[xii] No purchase necessary. Coupon is redeemable only for in-store purchases at participating Natural Grocers stores. Promotion subject to change without notice. Natural Grocers reserves the right to correct errors. Void where prohibited by law. Minimum $5 purchase required.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/natural-grocers-celebrates-moms-may-and-the-moments-that-matter-302440125.html

SOURCE Natural Grocers by Vitamin Cottage, Inc.

EMBRAER EARNINGS RESULTS 1st QUARTER 2025

PR Newswire

SÃO PAULO, May 6, 2025 /PRNewswire/ — EMBRAER S.A. (NYSE: ERJ; B3: EMBR3) RELEASES ITS FIRST QUARTER 2025 EARNINGS RESULTS.

HIGHLIGHTS

  • 2025 Guidance reiterated: Commercial Aviation deliveries between 77 and 85 aircraft, and Executive Aviation deliveries between 145 and 155 aircraft. Total company revenues in the US$7.0 to US$7.5 billion range, adjusted EBIT margin between +7.5% and +8.3%, and adjusted free cash flow of US$200 million or higher for the year. The company highlights Q1 results were not impacted by U.S. tariffs.
  • Revenues totaledUS$1,103 millionin 1Q25 – the best first quarter since 2016 – and +23% year over year (yoy). Highlight for Defense & Security revenues +72% yoy growth.
  • Adjusted EBIT reached US$62.0 million with a +5.6% margin in1Q25 (+0.8% in 1Q24).
  • Adjusted
    free cash flow
    w/o Eve was US$(385.8) million during the quarter in preparation for a higher number of aircraft deliveries in the coming quarters.
  • The company approved the payment of R$51.4 million in dividends (R$0.07 per share) related to 2024.
  • Embraer issued a US$650 million 10-year bond at 158bp over U.S. Treasury in 1Q25, and purchased US$522 million in 2027 bonds (fully retired) and US$150 million in 2028 bonds.
  • The company extended its debt duration to 6.3 years (3.8 years in 4Q) after the most recent liability management step, and ended the quarter with a 0.5x net debt-to-EBITDA ratio, down from 1.8x yoy.
  • Embraer delivered 30 jets in 1Q25, of which 7 were commercial jets (3 E2s and 4 E1s) and 23 were executive jets (14 light and 9 medium); +20% versus the 25 aircraft delivered yoy.
  • Firm order backlog
    of

    US$26.4 billion in 1Q25
    – surpassed the all-time historical high set in the previous quarter. For more information please see 1Q25 Backlog and Deliveries release.
  • To access the spreadsheet containing the data available in our Investor Relations website click here.

For additional information, please check the full document on our website ri.embraer.com.br

Investor Relations
Guilherme Paiva, Patrícia Mc Knight, Viviane Pinheiro, Eliane Fanis, Marilia Saback and Rodrigo Diniz.  
(+55 12)3927-6017
[email protected]
ri.embraer.com.br

CONFERENCE CALL INFORMATION
Embraer will host a conference call to present its 1Q25 results on:


Tuesday May 06, 2025



ENGLISH

: 8:00 AM (NY Time) / 9:00 AM (SP Time).
Translation to Portuguese.

To access the webcast click here.

Zoom webinar: 848 4607 1530

Or alternatively to participate by phone call:
U.S.:  +1(929)205-6099, +1(253)205-0468
Brazil:  +55(11)4632-2237, +55(11)4680-6788

We recommend you join 15 minutes in advance. 

 

Cision View original content:https://www.prnewswire.com/news-releases/embraer-earnings-results-1st-quarter-2025-302447154.html

SOURCE Embraer S.A.

ReNew Secures $100 Million Marquee Investment From BII to Boost India’s Solar Manufacturing Ecosystem

ReNew Secures $100 Million Marquee Investment From BII to Boost India’s Solar Manufacturing Ecosystem

BII’s investment will support expansion of domestic clean energy supply chain and create 2,000 new jobs

GURUGRAM, India–(BUSINESS WIRE)–
ReNew Energy Global Plc (“ReNew”), a leading decarbonisation solutions company, has secured an INR 8700 million (US$100 million) investment from British International Investment (“BII”), the UK’s development finance institution and impact investor, to accelerate the growth of its solar manufacturing business in India. The investment will be made in ReNew Photovoltaics Private Limited(“ReNew Photovoltaics” or “Company”), ReNew’s dedicated solar manufacturing subsidiary in India.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250506662753/en/

This marks BII’s first-ever investment in solar manufacturing in India and underscores its commitment to building a resilient, self-reliant renewable energy supply chain in one of the world’s fastest-growing clean energy markets.

The investment will see BII acquire a minority stake in ReNew Photovoltaics. The transaction is subject to customary approvals from lenders and regulatory authorities.

Established in 2021, ReNew Photovoltaics comprises an operational 6.4 GW solar PV module facility and a 2.5 GW solar cell facility, located in Jaipur, Rajasthan, and Dholera, Gujarat. BII’s investment will be primarily utilised to grow the business and expand the Company’s manufacturing capacity through the construction of a new state of the art 4 GW TOPCon cell facility in Dholera, Gujarat. Post-expansion, ReNew’s total manufacturing capacity will be approximately 6.4 GW of modules and 6.4 GW of cells. The expansion is expected to create over 2,000 new jobs and boost domestic production of high-efficiency solar components, reducing India’s reliance on imports and aligning with the Government of India’s 500 GW renewable energy capacity target by 2030 as well as the Make in India initiative.

With an annual output of 4.0 to 4.5 GW of modules, ReNew Photovoltaics’ facilities will primarily serve ReNew’s internal consumption, with surplus capacity targeted for third-party sales. To date, the facilities have supplied 900 MW to third parties along with additional orders of approximately 1.5 GW, reflecting strong market traction. Key supply partnerships with marquee customers, such as NTPC and Shakti Pumps, underscore high quality and reliability of ReNew Photovoltaics’ products. ReNew Photovoltaics will benefit significantly from the demand requirements, strong procurement capabilities as well as the broader ecosystem and relationships created by ReNew.

The partnership between BII and ReNew aligns with both organisations’ commitment to advancing India’s renewable energy landscape and contributing to global climate change mitigation efforts.

Sumant Sinha, Founder, Chairman & CEO, ReNew, said, “We are delighted to have BII as an investor in our solar manufacturing business. This partnership underscores our commitment to delivering high quality, top-tier products while making strategic investments that drive sustainable growth and create long-term shareholder value. Venturing into manufacturing was a strategic decision aimed at securing our supply chain, particularly as India advances its objective of indigenising the solar supply chain with a supportive regulatory and policy environment. Beyond ensuring supply stability, our goal was to partner with a like-minded, long-term partner in the manufacturing sector. Backward integration into the module supply chain further reinforces ReNew’s position as a leader in building a resilient, sustainable, and globally competitive clean energy platform.”

Sally Taylor, Minister Counsellor, Climate, Science and Tech, British High Commission, said, “This investment in ReNew’s solar manufacturing arm is a positive development that will diversify the supply of panels and further builds the strong partnership between the UK and India on clean energy. The UK Government is pressing ahead with our own clean energy transition, where the private sector is playing a key role, and we are keen to work with India and other countries showing domestic and international leadership on tackling climate change to protect our planet.”

Shilpa Kumar, MD and Head of India, BII, said, “We’re excited to partner with ReNew on our first venture into solar manufacturing in India. This investment is crucial for building and strengthening the renewable energy supply chain in India. Enhancing India’s capacity in solar manufacturing will not only boost clean energy generation but also reduce the country’s dependency on imports, promote sustainable industrialisation and create new jobs. It reinforces BII’s unwavering commitment to making investments that drive sustainable development and climate resilience in India.”

About ReNew

ReNew is a leading decarbonisation solutions company listed on Nasdaq (Nasdaq: RNW, RNWWW). ReNew’s clean energy portfolio of ~17.4 GWs on a gross basis as of February 14, 2025, is one of the largest globally. In addition to being a major independent power producer in India, we provide end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalisation, storage, and carbon markets that increasingly are integral to addressing climate change. For more information, visit www.renew.com and follow us on LinkedIn, Facebook, Twitter and Instagram.

About British International Investment:

British International Investment is the UK’s development finance institution and impact investor. As a trusted investment partner to businesses in Africa, Asia and the Caribbean, BII invests to create productive, sustainable and inclusive economies in our markets. Between 2022-2026, at least 30 per cent of BII’s total new commitments by value will be in climate finance. BII is also a founding member of the 2X Challenge which has raised over $33.6 billion to empower women’s economic development. The company has investments in over 1,580 businesses across 65 countries and total net assets of £8.5 billion. For more information, visit: www.bii.co.uk | watch here. Follow British International Investment on LinkedIn and X.

Press Enquiries

ReNew | [email protected]

Investor Enquiries

ReNew | Anunay Shahi, Nitin Vaid | [email protected]

BII | [email protected] | [email protected]

KEYWORDS: Ireland Asia Pacific United Kingdom Europe India

INDUSTRY KEYWORDS: Alternative Energy Energy Environment Climate Change

MEDIA:

Logo
Logo
Logo
Logo

TransDigm Group Reports Fiscal 2025 Second Quarter Results

PR Newswire


CLEVELAND
, May 6, 2025 /PRNewswire/ — TransDigm Group Incorporated (NYSE: TDG), a leading global designer, producer and supplier of highly engineered aircraft components, today reported results for the second quarter ended March 29, 2025.

Second quarter highlights include:

  • Net sales of $2,150 million, up 12% from $1,919 million in the prior year’s quarter;
  • Net income of $479 million, up 19% from the prior year’s quarter;
  • Earnings per share of $8.24, up 18% from the prior year’s quarter;
  • EBITDA As Defined of $1,162 million, up 14% from $1,021 million in the prior year’s quarter;
  • EBITDA As Defined margin of 54.0%;
  • Adjusted earnings per share of $9.11, up 14% from $7.99 in the prior year’s quarter; and
  • Reaffirming our previously stated fiscal 2025 financial guidance.

Quarter-to-Date Results

Net sales for the quarter increased 12.0%, or $231 million, to $2,150 million from $1,919 million in the comparable quarter a year ago. Organic sales growth as a percentage of net sales was 6.9%.

Net income for the quarter increased $75 million, or 18.6%, to $479 million from $404 million in the comparable quarter a year ago. The increase in net income primarily reflects the increase in net sales described above, the application of our value-driven operating strategy, lower one-time refinancing costs and lower non-cash stock and deferred compensation expense. The increase was partially offset by higher interest expense and income tax expense.

Adjusted net income for the quarter increased 14.5% to $529 million, or $9.11 per share, from $462 million, or $7.99 per share, in the comparable quarter a year ago.

EBITDA for the quarter increased 18.5% to $1,089 million from $919 million for the comparable quarter a year ago. EBITDA As Defined for the quarter increased 13.8% to $1,162 million compared with $1,021 million in the comparable quarter a year ago. EBITDA As Defined as a percentage of net sales for the quarter was 54.0% compared with 53.2% in the comparable quarter a year ago.

“I am very pleased with the operating results for the second quarter. We continued to see strong performance as we closed out the first half of our fiscal year,” stated Kevin Stein, TransDigm Group’s President and Chief Executive Officer. “The consolidated business performed well in the second quarter with revenue growth driven by the commercial aftermarket and defense market. Additionally, we had a robust EBITDA As Defined margin for the quarter — our margin improved to 54.0%, up approximately 80 basis points from the comparable prior year period.

During the quarter, we returned approximately $53 million of capital to shareholders via open market repurchases of our common stock. Subsequent to the quarter-end, we repurchased an additional $131 million of our common stock. We view these repurchases like any other capital investment, and we expect this investment will meet or exceed our long-term return objectives.

We remain deeply committed to our operating strategy with dedicated efforts across our teams to consistently focus on our value drivers and management of our cost structure. We look forward to the second half of our fiscal 2025 and the opportunity to continue driving value for our shareholders.” 

Share Repurchase Activity

During the second quarter of fiscal 2025, TransDigm repurchased 42,669 shares of its common stock at an average price per share of $1,249.52 for a total amount of approximately $53 million. For the twenty-six week period ended March 29, 2025, TransDigm repurchased 295,469 shares of its common stock at an average price per share of $1,248.78 for a total amount of approximately $369 million.

Subsequent to the quarter-end, in April 2025, TransDigm repurchased 105,567 shares of its common stock at an average price per share of $1,240.91 for a total amount of approximately $131 million.

Year-to-Date Results

Net sales for the twenty-six week period ended March 29, 2025 increased 12.1%, or $448 million, to $4,156 million from $3,708 million in the comparable period a year ago. Organic sales growth as a percentage of net sales was 6.8%.

Net income for the twenty-six week period ended March 29, 2025 increased $186 million, or 23.7%, to $972 million from $786 million in the comparable period a year ago. The increase in net income primarily reflects the increase in net sales described above, the application of our value-driven operating strategy, lower non-cash stock and deferred compensation expense and lower one-time refinancing costs. The increase was partially offset by higher interest expense and income tax expense.

GAAP earnings per share were reduced for the twenty-six week periods ended March 29, 2025 and March 30, 2024 by $0.83 per share and $1.75 per share, respectively, as a result of dividend equivalent payments made during each period. As a reminder, GAAP earnings per share are reduced when TransDigm makes dividend equivalent payments pursuant to its stock option plans. These dividend equivalent payments are made during TransDigm’s first fiscal quarter each year and also upon payment of any special dividends.

Adjusted net income for the twenty-six week period ended March 29, 2025 increased 12.7% to $986 million, or $16.94 per share, from $875 million, or $15.15 per share, in the comparable period a year ago.

EBITDA for the twenty-six week period ended March 29, 2025 increased 22.5% to $2,176 million from $1,777 million for the comparable period a year ago. EBITDA As Defined for the period increased 15.1% to $2,224 million compared with $1,933 million in the comparable period a year ago. EBITDA As Defined as a percentage of net sales for the period was 53.5% compared with 52.1% in the comparable period a year ago.

Please see the attached tables for a reconciliation of net income to EBITDA, EBITDA As Defined, and adjusted net income; a reconciliation of net cash provided by operating activities to EBITDA and EBITDA As Defined; and a reconciliation of earnings per share to adjusted earnings per share for the periods discussed in this press release.

Fiscal 2025 Outlook

Mr. Stein stated, “We are maintaining our previously issued fiscal 2025 financial guidance at this time. Additionally, we are maintaining the full year market channel growth assumption for the commercial aftermarket end market as underlying market fundamentals have not meaningfully changed. Our commercial OEM market and Defense market growth assumptions have been revised to reflect second quarter results and current expectations for the remainder of fiscal 2025.

The guidance incorporates the impact of recently enacted U.S. and non-U.S. tariffs. Based upon what we know today, we do not anticipate a material headwind from tariffs that we are unable to mitigate. The full-year guidance assumes no significant macroeconomic impacts or other factors, such as an economic recession, that could affect our business.

As the current environment is very dynamic, we will continue to evaluate our guidance and closely monitor our primary end markets as the year progresses.” 

TransDigm expects fiscal 2025 financial guidance to be as follows:

  • Net sales are anticipated to be in the range of $8,750 million to $8,950 million compared with $7,940 million in fiscal 2024, an increase of 11.5% at the midpoint;
  • Net income is anticipated to be in the range of $1,925 million to $2,037 million compared with $1,715 million in fiscal 2024, an increase of 15.5% at the midpoint;
  • Earnings per share is expected to be in the range of $32.27 to $34.19 per share based upon weighted average shares outstanding of 58.15 million shares, compared with $25.62 per share in fiscal 2024, which is an increase of 29.7% at the midpoint;
  • EBITDA As Defined is anticipated to be in the range of $4,615 million to $4,755 million compared with $4,173 million in fiscal 2024, an increase of 12.3% at the midpoint (corresponding to an EBITDA As Defined margin guide of approximately 52.9% for fiscal 2025);
  • Adjusted earnings per share is expected to be in the range of $35.51 to $37.43 per share compared with $33.99 per share in fiscal 2024, an increase of 7.3% at the midpoint; and
  • Fiscal 2025 outlook is based on the following market growth assumptions:
    • Commercial OEM revenue growth in the low single-digit to mid single-digit percentage range;
    • Commercial aftermarket revenue growth in the high single-digit to low double-digit percentage range; and
    • Defense revenue growth in the high single-digit to low double-digit percentage range.

Please see the attached Table 6 for a reconciliation of EBITDA, EBITDA As Defined to net income and reported earnings per share to adjusted earnings per share guidance midpoint estimated for the fiscal year ending September 30, 2025. Additionally, please see attached Table 7 for comparison of the current fiscal year 2025 guidance versus the previously issued fiscal year 2025 guidance.

Earnings Conference Call

TransDigm Group will host a conference call for investors and security analysts on May 6, 2025, beginning at 11:00 a.m., Eastern Time. To join the call telephonically, please register for the call at https://register-conf.media-server.com/register/BI1f1d402287494bed81594cfe098ee373. Once registered, participants will receive the dial-in information and a unique pin to access the call. The dial-in information and unique pin will be sent to the email used to register for the call. The unique pin is exclusive to the registrant and can only be used by one person at a time. A live audio webcast of the call can also be accessed online at https://www.transdigm.com. A slide presentation will also be available for reference during the conference call; go to the investor relations page of our website and click on “Presentations.”

The call will be archived on the website and available for replay at approximately 2:00 p.m., Eastern Time.

About TransDigm Group

TransDigm Group, through its wholly-owned subsidiaries, is a leading global designer, producer and supplier of highly engineered aircraft components for use on nearly all commercial and military aircraft in service today. Major product offerings, substantially all of which are ultimately provided to end-users in the aerospace industry, include mechanical/electro-mechanical actuators and controls, ignition systems and engine technology, specialized pumps and valves, power conditioning devices, specialized AC/DC electric motors and generators, batteries and chargers, engineered latching and locking devices, engineered rods, engineered connectors and elastomer sealing solutions, databus and power controls, cockpit security components and systems, specialized and advanced cockpit displays, engineered audio, radio and antenna systems, specialized lavatory components, seat belts and safety restraints, engineered and customized interior surfaces and related components, advanced sensor products, switches and relay panels, thermal protection and insulation, lighting and control technology, parachutes, high performance hoists, winches and lifting devices, and cargo loading, handling and delivery systems, specialized flight, wind tunnel and jet engine testing services and equipment, electronic components used in the generation, amplification, transmission and reception of microwave signals, and complex testing and instrumentation solutions.

Non-GAAP Supplemental Information

EBITDA, EBITDA As Defined, EBITDA As Defined margin, adjusted net income and adjusted earnings per share are non-GAAP financial measures presented in this press release as supplemental disclosures to net income and reported results. TransDigm Group defines EBITDA as earnings before interest, taxes, depreciation and amortization and defines EBITDA As Defined as EBITDA plus certain non-operating items recorded as corporate expenses, including non-cash compensation charges incurred in connection with TransDigm Group’s stock option or deferred compensation plans, foreign currency gains and losses, acquisition-integration costs, acquisition transaction-related expenses, and refinancing costs. Acquisition transaction and integration-related expenses represent costs incurred to integrate acquired businesses into TD Group’s operations; facility relocation costs and other acquisition-related costs; transaction and valuation-related costs for acquisitions comprising deal fees, legal, financial and tax due diligence expenses; and amortization expense of inventory step-up recorded in connection with the purchase accounting of acquired businesses. TransDigm Group defines adjusted net income as net income plus purchase accounting backlog amortization expense, effects from the sale on businesses, non-cash compensation charges incurred in connection with TransDigm Group’s stock option or deferred compensation plans, foreign currency gains and losses, acquisition-integration costs, acquisition transaction-related expenses, and refinancing costs. EBITDA As Defined margin represents EBITDA As Defined as a percentage of net sales. TransDigm Group defines adjusted diluted earnings per share as adjusted net income divided by the total outstanding shares for basic and diluted earnings per share. For more information regarding the computation of EBITDA, EBITDA As Defined, adjusted net income and adjusted earnings per share, please see the attached financial tables.

TransDigm Group presents these non-GAAP financial measures because it believes that they are useful indicators of its operating performance. TransDigm Group believes that EBITDA is useful to investors because it is frequently used by securities analysts, investors and other interested parties to measure operating performance among companies with different capital structures, effective tax rates and tax attributes, capitalized asset values and employee compensation structures, all of which can vary substantially from company to company. In addition, analysts, rating agencies and others use EBITDA to evaluate a company’s ability to incur and service debt. EBITDA As Defined is used to measure TransDigm Inc.’s compliance with the financial covenant contained in its credit facility. TransDigm Group’s management also uses EBITDA As Defined to review and assess its operating performance, to prepare its annual budget and financial projections and to review and evaluate its management team in connection with employee incentive programs. Moreover, TransDigm Group’s management uses EBITDA As Defined to evaluate acquisitions and as a liquidity measure. In addition, TransDigm Group’s management uses adjusted net income as a measure of comparable operating performance between time periods and among companies as it is reflective of changes in pricing decisions, cost controls and other factors that affect operating performance.

None of EBITDA, EBITDA As Defined, EBITDA As Defined margin, adjusted net income or adjusted earnings per share is a measurement of financial performance under U.S. GAAP and such financial measures should not be considered as an alternative to net income, operating income, earnings per share, cash flows from operating activities or other measures of performance determined in accordance with U.S. GAAP. In addition, TransDigm Group’s calculation of these non-GAAP financial measures may not be comparable to the calculation of similarly titled measures reported by other companies.

Although we use EBITDA and EBITDA As Defined as measures to assess the performance of our business and for the other purposes set forth above, the use of these non-GAAP financial measures as analytical tools has limitations, and you should not consider any of them in isolation, or as a substitute for analysis of our results of operations as reported in accordance with U.S. GAAP. Some of these limitations are:

  • neither EBITDA nor EBITDA As Defined reflects the significant interest expense, or the cash requirements, necessary to service interest payments on our indebtedness;
  • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and neither EBITDA nor EBITDA As Defined reflects any cash requirements for such replacements;
  • the omission of the substantial amortization expense associated with our intangible assets further limits the usefulness of EBITDA and EBITDA As Defined;
  • neither EBITDA nor EBITDA As Defined includes the payment of taxes, which is a necessary element of our operations; and
  • EBITDA As Defined excludes the cash expense we have incurred to integrate acquired businesses into our operations, which is a necessary element of certain of our acquisitions.

Forward-Looking Statements

Statements in this press release that are not historical facts, including statements under the heading “Fiscal 2025 Outlook,” are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “may,” “will,” “should,” “expect,” “intend,” “plan,” “predict,” “anticipate,” “estimate,” or “continue” and other words and terms of similar meaning may identify forward-looking statements.

All forward-looking statements involve risks and uncertainties that could cause TransDigm Group’s actual results to differ materially from those expressed or implied in any forward-looking statements made by, or on behalf of, TransDigm Group. These risks and uncertainties include but are not limited to: the sensitivity of our business to the number of flight hours that our customers’ planes spend aloft and our customers’ profitability, both of which are affected by general economic conditions; supply chain constraints; increases in raw material costs, taxes and labor costs that cannot be recovered in product pricing; failure to complete or successfully integrate acquisitions; our indebtedness; current and future geopolitical or other worldwide events, including, without limitation, wars or conflicts and public health crises; cybersecurity threats; risks related to the transition or physical impacts of climate change and other natural disasters or meeting sustainability-related voluntary goals or regulatory requirements; our reliance on certain customers; the United States (“U.S.”) defense budget and risks associated with being a government supplier including government audits and investigations; failure to maintain government or industry approvals; risks related to changes in laws and regulations, including increases in compliance costs and potential changes in trade policies and tariffs; potential environmental liabilities; liabilities arising in connection with litigation; risks and costs associated with our international sales and operations; and other factors. Further information regarding the important factors that could cause actual results to differ materially from projected results can be found in TransDigm Group’s most recent Annual Report on Form 10-K and other reports that TransDigm Group or its subsidiaries have filed with the Securities and Exchange Commission. Except as required by law, TransDigm Group undertakes no obligation to revise or update the forward-looking statements contained in this press release.


Contact:

Investor Relations

216-706-2945

[email protected]


TRANSDIGM GROUP INCORPORATED


CONSOLIDATED STATEMENTS OF INCOME


FOR THE THIRTEEN AND TWENTY-SIX WEEK PERIODS ENDED


Table 1


MARCH 29, 2025 AND MARCH 30, 2024


(Amounts in millions, except per share amounts)


(Unaudited)


Thirteen Week Periods Ended


Twenty-Six Week Periods Ended


March 29, 2025


March 30, 2024


March 29, 2025


March 30, 2024

NET SALES

$           2,150

$           1,919

$           4,156

$           3,708

COST OF SALES

876

767

1,647

1,515

GROSS PROFIT

1,274

1,152

2,509

2,193

SELLING AND ADMINISTRATIVE EXPENSES

236

248

447

467

AMORTIZATION OF INTANGIBLE ASSETS

47

37

97

72

INCOME FROM OPERATIONS

991

867

1,965

1,654

INTEREST EXPENSE—NET

378

326

756

626

REFINANCING COSTS

28

28

OTHER INCOME

(9)

(6)

(32)

(8)

INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

622

519

1,241

1,008

INCOME TAX PROVISION

143

115

269

222

NET INCOME

479

404

972

786

LESS: NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS

(1)

(1)

NET INCOME ATTRIBUTABLE TO TD GROUP

$              479

$              403

$              972

$              785

NET INCOME APPLICABLE TO TD GROUP COMMON STOCKHOLDERS

$              479

$              403

$              923

$              684

Earnings per share attributable to TD Group common stockholders:

Earnings per share—Basic and diluted

$             8.24

$             6.97

$           15.86

$           11.83

Cash dividends declared per common share

$                 —

$                 —

$                 —

$           35.00

Weighted-average shares outstanding:

Basic and diluted

58.1

57.8

58.2

57.8

 


TRANSDIGM GROUP INCORPORATED


SUPPLEMENTAL INFORMATION – RECONCILIATION OF


EBITDA, EBITDA AS DEFINED TO NET INCOME


FOR THE THIRTEEN AND TWENTY-SIX WEEK PERIODS ENDED


Table 2


MARCH 29, 2025 AND MARCH 30, 2024


(Amounts in millions, except per share amounts)


(Unaudited)


Thirteen Week Periods Ended


Twenty-Six Week Periods Ended


March 29, 2025


March 30, 2024


March 29, 2025


March 30, 2024

Net Income

$           479

$           404

$           972

$           786

Adjustments:

Depreciation and amortization expense

89

74

179

143

Interest expense-net

378

326

756

626

Income tax provision

143

115

269

222

EBITDA

1,089

919

2,176

1,777

Adjustments:

Acquisition transaction and integration-related expenses (1)

9

14

22

16

Non-cash stock and deferred compensation expense (2)

48

60

73

111

Refinancing costs (3)

28

28

Other, net (4)

16

(47)

1

Gross Adjustments to EBITDA

73

102

48

156

EBITDA As Defined

$       1,162

$       1,021

$       2,224

$       1,933

EBITDA As Defined Margin (5)

54.0 %

53.2 %

53.5 %

52.1 %

_____________________


(1)

Represents costs incurred to integrate acquired businesses into TD Group’s operations; facility relocation costs and other acquisition-related costs; transaction and valuation-related costs for acquisitions comprising deal fees, legal, financial and tax due diligence expenses; and amortization expense of inventory step-up recorded in connection with the purchase accounting of acquired businesses.


(2)

Represents the compensation expense recognized by TD Group under our stock option plans and deferred compensation plans.


(3)

Represents costs expensed related to debt financing activities, including new issuances, extinguishments, refinancings and amendments to existing agreements.


(4)

Primarily represents foreign currency transaction (gains) or losses, payroll withholding taxes related to dividend equivalent payments and stock option exercises, non-service related pension costs, deferred compensation payments and other miscellaneous (income) expense, such as gain on sale of business.


(5)

The EBITDA As Defined Margin represents the amount of EBITDA As Defined as a percentage of net sales.

 


TRANSDIGM GROUP INCORPORATED


SUPPLEMENTAL INFORMATION – RECONCILIATION OF REPORTED


EARNINGS PER SHARE TO ADJUSTED EARNINGS PER SHARE


FOR THE THIRTEEN AND TWENTY-SIX WEEK PERIODS ENDED


Table 3


MARCH 29, 2025 AND MARCH 30, 2024


(Amounts in millions, except per share amounts)


(Unaudited)


Thirteen Week Periods Ended


Twenty-Six Week Periods Ended


March 29, 2025


March 30, 2024


March 29, 2025


March 30, 2024


Reported Earnings Per Share

Net income

$                479

$                404

$                972

$                786

Less: Net income attributable to noncontrolling interests

(1)

(1)

Net income attributable to TD Group

479

403

972

785

Less: Dividends paid on participating securities

(49)

(101)

Net income applicable to TD Group common stockholders—basic and diluted

$                479

$                403

$                923

$                684


Weighted-average shares outstanding under the two-class method

Weighted-average common shares outstanding

56.1

55.7

56.2

55.6

Vested options deemed participating securities

2.0

2.1

2.0

2.2

Total shares for basic and diluted earnings per share

58.1

57.8

58.2

57.8

Earnings per share—basic and diluted

$               8.24

$               6.97

$             15.86

$             11.83


Adjusted Earnings Per Share

Net income

$                479

$                404

$                972

$                786

Gross Adjustments to EBITDA

73

102

48

156

Purchase Accounting Backlog Amortization

2

3

8

3

Tax adjustment (1)

(25)

(47)

(42)

(70)

Adjusted net income

$                529

$                462

$                986

$                875

Adjusted diluted earnings per share under the two-class method

$               9.11

$               7.99

$             16.94

$             15.15


Diluted Earnings Per Share to Adjusted Earnings Per Share

Diluted earnings per share from net income attributable to TD Group

$               8.24

$               6.97

$             15.86

$             11.83

Adjustments to diluted earnings per share:

  Inclusion of the dividend equivalent payments

0.83

1.75

Acquisition transaction and integration-related expenses

0.14

0.21

0.40

0.25

Non-cash stock and deferred compensation expense

0.62

0.77

0.95

1.44

Refinancing costs

0.37

0.37

Tax adjustment on income from continuing operations before taxes (1)

(0.11)

(0.33)

(0.48)

(0.52)

   Other, net

0.22

(0.62)

0.03

Adjusted earnings per share

$               9.11

$               7.99

$             16.94

$             15.15

_____________________


(1)

For the thirteen and twenty-six week periods ended March 29, 2025 and March 30, 2024, the Tax adjustment represents the tax effect of the adjustments at the applicable effective tax rate, as well as the impact on the effective tax rate when excluding the excess tax benefits on stock option exercises. Stock compensation expense is excluded from adjusted net income and therefore we have excluded the impact that the excess tax benefits on stock option exercises have on the effective tax rate for determining adjusted net income.

 


TRANSDIGM GROUP INCORPORATED


SUPPLEMENTAL INFORMATION – RECONCILIATION OF NET CASH


PROVIDED BY OPERATING ACTIVITIES TO EBITDA, EBITDA AS DEFINED


FOR THE TWENTY-SIX WEEK PERIODS ENDED


Table 4


MARCH 29, 2025 AND MARCH 30, 2024


(Amounts in millions)


(Unaudited)


Twenty-Six Week Periods Ended


March 29, 2025


March 30, 2024

Net cash provided by operating activities

$              900

$              865

Adjustments:

Changes in assets and liabilities, net of effects from acquisitions and sales of businesses

289

215

Interest expense-net (1)

737

604

Income tax provision-current

271

223

Amortization of inventory step-up

(7)

(3)

Loss contract amortization

30

17

Refinancing costs (2)

(28)

Gain on sale of businesses, net

19

Non-cash stock and deferred compensation expense (3)

(73)

(111)

Foreign currency exchange gains (losses)

10

(5)

EBITDA

2,176

1,777

Adjustments:

Acquisition transaction and integration-related expenses (4)

22

16

Non-cash stock and deferred compensation expense (3)

73

111

Refinancing costs (2)

28

Other, net (5)

(47)

1

EBITDA As Defined

$           2,224

$           1,933

_____________________


(1)

Represents interest expense, net of interest income, excluding the amortization of debt issuance costs and discount on debt.


(2)

Represents costs expensed related to debt financing activities, including new issuances, extinguishments, refinancings and amendments to existing agreements.


(3)

Represents the compensation expense recognized by TD Group under our stock option plans and deferred compensation plans.


(4)

Represents costs incurred to integrate acquired businesses into TD Group’s operations; facility relocation costs and other acquisition-related costs; transaction and valuation-related costs for acquisitions comprising deal fees, legal, financial and tax due diligence expenses; and amortization expense of inventory step-up recorded in connection with the purchase accounting of acquired businesses.


(5)

Primarily represents foreign currency transaction (gains) or losses, payroll withholding taxes related to dividend equivalent payments and stock option exercises, non-service related pension costs, deferred compensation payments and other miscellaneous (income) expense, such as gain on sale of business.

 


TRANSDIGM GROUP INCORPORATED


SUPPLEMENTAL INFORMATION – BALANCE SHEET DATA


Table 5


(Amounts in millions)


(Unaudited)


March 29, 2025


September 30, 2024

Cash and cash equivalents

$                  2,426

$                  6,261

Trade accounts receivable—Net

1,442

1,381

Inventories—Net

2,010

1,876

Current portion of long-term debt

94

98

Short-term borrowings—trade receivable securitization facility

649

486

Accounts payable

319

323

Dividends payable

4,216

Accrued and other current liabilities

1,012

1,216

Long-term debt

24,306

24,296

Total TD Group stockholders’ deficit

(5,671)

(6,290)

 


TRANSDIGM GROUP INCORPORATED


SUPPLEMENTAL INFORMATION – RECONCILIATION OF EBITDA,


EBITDA AS DEFINED TO NET INCOME AND REPORTED EARNINGS PER


SHARE TO ADJUSTED EARNINGS PER SHARE GUIDANCE MIDPOINT


FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2025


Table 6


(Amounts in millions, except per share amounts)


(Unaudited)


GUIDANCE MIDPOINT


Fiscal Year Ended
September 30, 2025

Net Income

$                                    1,981

Adjustments:

Depreciation and amortization expense

380

Interest expense-net

1,540

Income tax provision

625

EBITDA

4,526

Adjustments:

Acquisition transaction and integration-related expenses (1)

30

Non-cash stock and deferred compensation expense (1)

180

Other, net (1)

(51)

Gross Adjustments to EBITDA

159

EBITDA As Defined

$                                    4,685

EBITDA As Defined Margin (1)

52.9 %

Earnings per share

$                                    33.23

Adjustments to earnings per share:

Inclusion of the dividend equivalent payments

0.83

Acquisition transaction and integration-related expenses

0.76

Non-cash stock and deferred compensation expense

2.35

Other, net

(0.70)

Adjusted earnings per share

$                                    36.47

Weighted-average shares outstanding

58.15

_____________________


(1)

Refer to Table 2 above for definitions of Non-GAAP measurement adjustments.

 


TRANSDIGM GROUP INCORPORATED


SUPPLEMENTAL INFORMATION


CURRENT FISCAL YEAR 2025 GUIDANCE VERSUS


PRIOR FISCAL YEAR 2025 GUIDANCE


Table 7


(Amounts in millions, except per share amounts)


(Unaudited)


Current

Fiscal Year 2025
Guidance Issued
May 6, 2025


Prior

Fiscal Year 2025
Guidance Issued
February 4, 2025


Change at
Midpoint

Net Sales

$8,750 to $8,950

$8,750 to $8,950

$—

GAAP Net Income

$1,925 to $2,037

$1,925 to $2,037

$—

GAAP Earnings Per Share

$32.27 to $34.19

$32.27 to $34.19

$—

EBITDA As Defined

$4,615 to $4,755

$4,615 to $4,755

$—

Adjusted Earnings Per Share

$35.51 to $37.43

$35.51 to $37.43

$—

Weighted-Average Shares Outstanding

58.15

58.15

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/transdigm-group-reports-fiscal-2025-second-quarter-results-302447082.html

SOURCE TransDigm Group Inc.

Driven Brands Holdings Inc. Reports First Quarter 2025 Results

Driven Brands Holdings Inc. Reports First Quarter 2025 Results

–17th consecutive quarter of same store sales growth–

–Take 5 Oil Change delivers revenue growth of 15% and same store sales growth of 8%–

–Completed divestiture of U.S. car wash business in April 2025–

–Reaffirms fiscal year 2025 outlook–

CHARLOTTE, N.C.–(BUSINESS WIRE)–
Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven Brands” or the “Company”) today reported financial results for the first quarter ending March 29, 2025.

For the first quarter, Driven Brands delivered revenue of $516.2 million, an increase of 7% versus the prior year. System-wide sales increased 2% to $1.5 billion, driven by a 1% increase in same store sales and 4% increase in store count versus the prior year.

Net income was $6 million or $0.04 per diluted share versus net income of $4 million or $0.02 per diluted share in the prior year. Adjusted Net Income1 was $44 million or $0.27 per diluted share versus $40 million or $0.25 per diluted share in the prior year. Adjusted EBITDA1 was $125 million, up 2% versus the prior year.

“We delivered another strong quarter, led by the sustained momentum of our Take 5 Oil Change business, which achieved its 19th consecutive quarter of same store sales growth. Additionally, we successfully completed the sale of our U.S. car wash business in early April, primarily using the proceeds to reduce our debt. While the economic environment is fluid, our diversified portfolio, anchored by non-discretionary services, demonstrates resilience and positions us well for the long term. We are confident in our ability to deliver on our 2025 outlook and remain committed to paying down debt as we grow the business,” said Jonathan Fitzpatrick, President and Chief Executive Officer.

“I would like to congratulate Danny Rivera as he steps into the role of CEO. I am pleased to remain on the board as Chair and look forward to supporting Danny in his well-deserved new role and the continued growth of Driven Brands,” Fitzpatrick concluded.

First Quarter 2025 Key Performance Indicators by Segment

 

System-wide Sales (in millions)

Store Count

Same Store Sales2

Revenue

(in millions)

Adjusted EBITDA

(in millions)

Take 5

$

387.5

1,203

8.0

%

$

293.4

$

100.9

 

Franchise Brands

 

1,033.4

2,660

(2.9

)%

 

71.7

 

44.4

 

Car Wash

 

66.6

718

26.2

%

 

68.0

 

24.4

 

Corporate and Other

 

59.3

216

N/A

 

 

83.0

 

(44.6

)

Total

$

1,546.8

4,797

0.7

%

 

516.2

 

125.1

 

Capital and Liquidity

The Company ended the first quarter with total liquidity of $640.8 million consisting of $152.0 million in cash and cash equivalents and $488.7 million of undrawn capacity on its variable funding securitization senior notes and revolving credit facility. This did not include the additional $135.0 million Series 2022 Class A-1 Notes that expand the Company’s variable funding note borrowing capacity if the Company elects to exercise them, assuming certain conditions continue to be met.

Fiscal Year 2025 Outlook

The Company reaffirms its financial outlook for fiscal year 2025 ending December 27, 2025.

 

2025 Outlook

Revenue

~$2.05 – $2.15 billion

Adjusted EBITDA1

~$520 – $550 million

Adjusted Diluted EPS1

~$1.15 – $1.25

The Company also expects:

  • Same store sales growth of 1% – 3%
  • Net store growth of approximately 175 – 200

Note: 2025 Outlook excludes the impact of any potential M&A and divestitures other than the completed sale of the U.S. car wash business.

1 Adjusted EBITDA, Adjusted Net Income and Adjusted EPS are non-GAAP financial measures. See “Reconciliation of Non-GAAP Financial Measures” for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein.

2 The Company does not provide same store sales results for Corporate and Other as it is a non-reportable segment. The same store sales results for any applicable businesses within Corporate and Other are included in the Company’s overall same store sales results.

Conference Call

Driven Brands will host a conference call to discuss first quarter 2025 results today, Tuesday, May 6, at 8:30 a.m. ET. The call will be available by webcast and can be accessed by visiting Driven Brands’ Investor Relations website at investors.drivenbrands.com. A replay of the call will be available for at least three months.

About Driven Brands

Driven Brands, headquartered in Charlotte, NC, is the largest automotive services company in North America, providing a range of consumer and commercial automotive services, including paint, collision, glass, vehicle repair, oil change, maintenance and car wash. Driven Brands is the parent company of some of North America’s leading automotive service businesses including Take 5 Oil Change®, Meineke Car Care Centers®, Maaco®, 1-800-Radiator & A/C®, Auto Glass Now®, and CARSTAR®. Driven Brands has approximately 4,800 locations across the United States and 13 other countries, and services tens of millions of vehicles annually. Driven Brands’ network generates approximately $2.0 billion in annual revenue from approximately $6.1 billion in system-wide sales.

Disclosure Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are generally identified by the use of forward-looking terminology, including the terms “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “likely,” “may,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and, in each case, their negative or other various or comparable terminology. All statements other than statements of historical facts contained in this Press Release, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, trends, plans, objectives of management, impact of accounting standards and outlook, impairments, and expected market growth are forward-looking statements. In particular, forward-looking statements include, among other things, statements relating to: (i) our ability to realize the value of the note received as partial payment in the sale of our U.S. Car Wash business; (ii) potential post-closing obligations and liabilities relating to the sale of our U.S. Car Wash business; (iii) the current geopolitical environment, including the impact, both direct and indirect, of government actions, such as proposed and enacted tariffs; (iv) our strategy, outlook, and growth prospects; (v) our operational and financial targets and dividend policy; (vi) general economic trends and trends in the industry and markets; (vii) the risks and costs associated with the integration of, and or ability to integrate, our stores and business units successfully; (viii) the proper application of generally accepted accounting principles, which are highly complex and involve many subjective assumptions, estimates, and judgments; and (ix) the competitive environment in which we operate. Forward-looking statements are not based on historical facts, but instead represent our current expectations and assumptions regarding our business, the economy and other future conditions, and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. It is not possible to predict or identify all such risks. These risks include, but are not limited to, the risk factors that are described under the section titled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 28, 2024 as well as in our other filings with the Securities and Exchange Commission, which are available on its website at www.sec.gov. Given these uncertainties, you should not place undue reliance on these forward-looking statements.

DRIVEN BRANDS HOLDINGS INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

 

 

Three Months Ended

(in thousands, except per share amounts)

March 29, 2025

 

March 30, 2024

Net revenue:

 

 

 

Franchise royalties and fees

$

44,710

 

 

$

45,045

 

Company-operated store sales

 

314,131

 

 

 

284,229

 

Independently-operated store sales

 

66,640

 

 

 

53,047

 

Advertising contributions

 

25,325

 

 

 

24,070

 

Supply and other revenue

 

65,357

 

 

 

75,601

 

Total net revenue

 

516,163

 

 

 

481,992

 

Operating Expenses:

 

 

 

Company-operated store expenses

 

181,866

 

 

 

169,342

 

Independently-operated store expenses

 

36,475

 

 

 

29,355

 

Advertising expenses

 

25,325

 

 

 

24,070

 

Supply and other expenses

 

35,028

 

 

 

36,216

 

Selling, general, and administrative expenses

 

143,052

 

 

 

123,811

 

Depreciation and amortization

 

33,152

 

 

 

31,116

 

Total operating expenses

 

454,898

 

 

 

413,910

 

Operating income

 

61,265

 

 

 

68,082

 

Other expenses, net:

 

 

 

Interest expense, net

 

36,534

 

 

 

43,751

 

Foreign currency transaction loss, net

 

210

 

 

 

4,321

 

Other expenses, net

 

36,744

 

 

 

48,072

 

Income before taxes from continuing operations

 

24,521

 

 

 

20,010

 

Income tax expense

 

7,031

 

 

 

8,458

 

Net income from continuing operations

 

17,490

 

 

$

11,552

 

Net loss from discontinued operations, net of tax

 

(11,984

)

 

$

(7,291

)

Net income

$

5,506

 

 

$

4,261

 

 

 

 

 

Basic earnings (loss) per share:

 

 

 

Continuing Operations

$

0.11

 

 

$

0.07

 

Discontinued Operations

 

(0.07

)

 

 

(0.04

)

Net basic earnings per share

$

0.04

 

 

$

0.03

 

 

 

 

 

Diluted earnings (loss) per share:

 

 

 

Continuing Operations

$

0.11

 

 

$

0.07

 

Discontinued Operations

 

(0.07

)

 

 

(0.05

)

Net diluted earnings per share

$

0.04

 

 

$

0.02

 

 

 

 

 

Weighted average shares outstanding

 

 

 

Basic

 

160,568

 

 

 

159,631

 

Diluted

 

161,818

 

 

 

160,604

 

DRIVEN BRANDS HOLDINGS INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

 

(in thousands, except share and per share amounts)

March 29, 2025

 

December 28, 2024

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

152,042

 

 

$

149,573

 

Restricted cash

 

332

 

 

 

358

 

Accounts and notes receivable, net

 

201,217

 

 

 

177,654

 

Inventory

 

63,829

 

 

 

66,539

 

Prepaid and other assets

 

47,771

 

 

 

37,841

 

Income tax receivable

 

12,917

 

 

 

14,294

 

Advertising fund assets, restricted

 

55,140

 

 

 

49,716

 

Assets held for sale

 

70,691

 

 

 

77,616

 

Current assets of discontinued operations

 

67,442

 

 

 

83,847

 

Total current assets

 

671,381

 

 

 

657,438

 

Other assets

 

127,278

 

 

 

125,422

 

Property and equipment, net

 

734,511

 

 

 

711,505

 

Operating lease right-of-use assets

 

535,242

 

 

 

524,442

 

Deferred commissions

 

7,315

 

 

 

7,246

 

Intangibles, net

 

662,417

 

 

 

665,896

 

Goodwill

 

1,413,298

 

 

 

1,403,056

 

Deferred tax assets

 

8,363

 

 

 

8,206

 

Non-current assets of discontinued operations

 

1,141,846

 

 

 

1,158,576

 

Total assets

$

5,301,651

 

 

$

5,261,787

 

Liabilities and shareholders’ equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

110,377

 

 

$

85,843

 

Accrued expenses and other liabilities

 

201,955

 

 

 

193,638

 

Income tax payable

 

1,518

 

 

 

6,860

 

Current portion of long-term debt

 

32,234

 

 

 

32,232

 

Income tax receivable liability

 

22,674

 

 

 

22,676

 

Advertising fund liabilities

 

24,058

 

 

 

22,030

 

Current liabilities of discontinued operations

 

64,490

 

 

 

70,616

 

Total current liabilities

 

457,306

 

 

 

433,895

 

Long-term debt

 

2,616,272

 

 

 

2,656,308

 

Deferred tax liabilities

 

94,165

 

 

 

87,485

 

Operating lease liabilities

 

505,980

 

 

 

491,282

 

Income tax receivable liability

 

110,907

 

 

 

110,935

 

Deferred revenue

 

31,060

 

 

 

31,314

 

Long-term accrued expenses and other liabilities

 

19,867

 

 

 

20,122

 

Non-current liabilities of discontinued operations

 

822,851

 

 

 

823,112

 

Total liabilities

 

4,658,408

 

 

 

4,654,453

 

Preferred Stock $0.01 par value; 100,000,000 shares authorized; none issued or outstanding

 

 

 

 

 

Common stock, $0.01 par value, 900,000,000 shares authorized: and 164,274,617 and 163,842,248 shares outstanding; respectively

 

1,643

 

 

 

1,638

 

Additional paid-in capital

 

1,709,580

 

 

 

1,699,851

 

Accumulated deficit

 

(997,077

)

 

 

(1,002,583

)

Accumulated other comprehensive loss

 

(70,903

)

 

 

(91,572

)

Total shareholders’ equity

 

643,243

 

 

 

607,334

 

Total liabilities and shareholders’ equity

$

5,301,651

 

 

$

5,261,787

 

 

DRIVEN BRANDS HOLDINGS INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 

 

Three Months Ended

(in thousands)

March 29, 2025

 

March 30, 2024

Net income

$

5,506

 

 

$

4,261

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation and amortization

 

35,355

 

 

 

43,229

 

Share-based compensation expense

 

11,788

 

 

 

11,861

 

(Gain) loss on foreign denominated transactions

 

(132

)

 

 

7,574

 

Loss (gain) on foreign currency derivatives

 

342

 

 

 

(3,253

)

Loss (gain) on sale and disposal of businesses, fixed assets, and sale leaseback transactions

 

12,933

 

 

 

5,434

 

Reclassification of interest rate hedge to income

 

(514

)

 

 

(519

)

Bad debt expense

 

4,510

 

 

 

2,070

 

Asset impairment charges and lease terminations

 

5,813

 

 

 

979

 

Amortization of deferred financing costs and bond discounts

 

3,089

 

 

 

1,954

 

Amortization of cloud computing

 

1,881

 

 

 

1,345

 

Provision (benefit) for deferred income taxes

 

4,540

 

 

 

(2,807

)

Other, net

 

(6,985

)

 

 

10,669

 

Changes in operating assets and liabilities, net of acquisitions:

 

 

 

Accounts and notes receivable, net

 

(26,449

)

 

 

(17,351

)

Inventory

 

3,310

 

 

 

(1,005

)

Prepaid and other assets

 

(5,079

)

 

 

(4,270

)

Advertising fund assets and liabilities, restricted

 

(4,091

)

 

 

7,650

 

Other assets

 

(2,584

)

 

 

(33,300

)

Deferred commissions

 

69

 

 

 

(331

)

Deferred revenue

 

(255

)

 

 

1,659

 

Accounts payable

 

20,847

 

 

 

14,165

 

Accrued expenses and other liabilities

 

18,122

 

 

 

6,293

 

Income tax receivable

 

(6,885

)

 

 

3,976

 

Cash provided by operating activities

 

75,131

 

 

 

60,283

 

Cash flows from investing activities:

 

 

 

Capital expenditures

 

(56,227

)

 

 

(89,483

)

Cash used in business acquisitions, net of cash acquired

 

 

 

 

(2,024

)

Proceeds from sale leaseback transactions

 

8,696

 

 

 

4,550

 

Proceeds from sale or disposal of businesses and fixed assets

 

3,519

 

 

 

52,677

 

Cash used in investing activities

 

(44,012

)

 

 

(34,280

)

Cash flows from financing activities:

 

 

 

Payment of debt extinguishment and issuance costs

 

(1,414

)

 

 

 

Repayment of long-term debt

 

(32,418

)

 

 

(7,616

)

Proceeds from revolving lines of credit and short-term debt

 

33,000

 

 

 

46,000

 

Repayment of revolving lines of credit and short-term debt

 

(43,000

)

 

 

(46,000

)

Repayment of principal portion of finance lease liability

 

(1,353

)

 

 

(886

)

Payment of Tax Receivable Agreement

 

 

 

 

(24,718

)

Tax obligations for share-based compensation

 

(2,582

)

 

 

 

Cash used in financing activities

 

(47,767

)

 

 

(33,220

)

Effect of exchange rate changes on cash

 

1,549

 

 

 

1,133

 

Net change in cash, cash equivalents, restricted cash, and cash included in advertising fund assets, restricted

 

(15,099

)

 

 

(6,084

)

Cash and cash equivalents, beginning of period

 

169,954

 

 

 

176,522

 

Cash included in advertising fund assets, restricted, beginning of period

 

38,930

 

 

 

38,537

 

Restricted cash, beginning of period

 

358

 

 

 

657

 

Cash, cash equivalents, restricted cash, and cash included in advertising fund assets, restricted, beginning of period

 

209,242

 

 

 

215,716

 

Cash and cash equivalents, end of period

 

155,584

 

 

 

165,513

 

Cash included in advertising fund assets, restricted, end of period

 

38,227

 

 

 

43,462

 

Restricted cash, end of period

 

332

 

 

 

657

 

Cash, cash equivalents, restricted cash, and cash included in advertising fund assets, restricted, end of period

$

194,143

 

 

$

209,632

 

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The Company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.

Non-GAAP Financial Measures in Outlook

Driven Brands includes Adjusted Earnings Before Interest, Tax, Depreciation and Amortization (“Adjusted EBITDA”) and Adjusted Earnings per Share (“Adjusted EPS”) in the Company’s Fiscal Year 2025 Outlook. Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and have not been reconciled to the most comparable GAAP financial measures because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management’s control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide an outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the SEC.

Adjusted Net Income and Adjusted Earnings Per Share

Adjusted Net Income and Adjusted EPS are considered non-GAAP financial measures under the SEC’s rules because they exclude certain amounts included in the net income attributable to Driven Brands common stockholders and diluted earnings per share attributable to Driven Brands common stockholders calculated in accordance with GAAP. Management believes that Adjusted Net Income and Adjusted EPS are meaningful measures to share with investors because they facilitate comparison of the current period performance with that of the comparable prior period. In addition, Adjusted Net Income and Adjusted EPS afford investors a view of what management considers to be Driven Brands’ core earnings performance as well as the ability to make a more informed assessment of such earnings performance with that of the prior period.

The tables below reflect the calculation of Adjusted Net Income and Adjusted Earnings Per Share for the three months ended March 29, 2025, compared to the three months ended March 30, 2024.

Net Income to Adjusted Net Income and Adjusted Earnings Per Share (Unaudited)

 

Three Months Ended

(in thousands, except per share data)

March 29, 2025

 

March 30, 2024

Net income from continuing operations

$

17,490

 

 

$

11,552

 

Adjustments:

 

 

 

Acquisition related costs(a)

 

15

 

 

 

1,701

 

Non-core items and project costs, net(b)

 

5,244

 

 

 

4,711

 

Cloud computing amortization(c)

 

1,881

 

 

 

1,345

 

Share-based compensation expense(d)

 

11,788

 

 

 

11,861

 

Foreign currency transaction loss, net(e)

 

210

 

 

 

4,321

 

Asset sale leaseback (gain) loss, net, impairment and closed store expenses(f)

 

11,753

 

 

 

3,976

 

Amortization related to acquired intangible assets(g)

 

4,659

 

 

 

6,415

 

Valuation allowance for deferred tax asset(h)

 

299

 

 

 

1,134

 

Adjusted net income before tax impact of adjustments

$

53,339

 

 

$

47,016

 

Tax impact of adjustments(i)

 

(9,160

)

 

 

(7,004

)

Adjusted net income from continuing operations

$

44,179

 

 

$

40,012

 

 

 

 

 

Basic earnings per share from continuing operations

$

0.11

 

 

$

0.07

 

Diluted earnings per share from continuing operations

$

0.11

 

 

$

0.07

 

 

 

 

 

Adjusted basic earnings per share from continuing operations

$

0.27

 

 

$

0.25

 

Adjusted diluted earnings per share from continuing operations

$

0.27

 

 

$

0.25

 

 

 

 

 

Weighted average shares outstanding

 

 

 

Basic

 

160,568

 

 

 

159,631

 

Diluted

 

161,818

 

 

 

160,604

 

(1)

 

Adjusted Earnings Per Share is calculated under the two-class method. Under the two-class method, adjusted earnings per share is calculated using adjusted net income attributable to common shares, which is derived by reducing adjusted net income by the amount attributable to participating securities. Adjusted Net Income attributable to participating securities used in the basic and diluted earnings per share calculations was less than $1 million for the three months ended March 29, 2025 and March 30, 2024.

Adjusted EBITDA

Adjusted EBITDA is considered a non-GAAP financial measure under the Securities and Exchange Commission’s (“SEC”) rules because it excludes certain amounts included in net income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Driven Brand’s core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period.

Please see the company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2024, filed with the SEC on February 28, 2024, for additional information on Adjusted EBITDA. The tables below reflect the calculation of Adjusted EBITDA for the three months ended March 29, 2025, compared to the three months ended March 30, 2024.

Net Income to Adjusted EBITDA Reconciliation (Unaudited)

 

Three Months Ended

(in thousands)

March 29, 2025

 

March 30, 2024

Net income from continuing operations

$

17,490

 

$

11,552

Income tax expense

 

7,031

 

 

8,458

Interest expense, net

 

36,534

 

 

43,751

Depreciation and amortization

 

33,152

 

 

31,116

EBITDA

 

94,207

 

 

94,877

Acquisition related costs(a)

 

15

 

 

1,701

Non-core items and project costs, net(b)

 

5,244

 

 

4,711

Cloud computing amortization(c)

 

1,881

 

 

1,345

Share-based compensation expense(d)

 

11,788

 

 

11,861

Foreign currency transaction loss, net(e)

 

210

 

 

4,321

Asset sale leaseback (gain) loss, net, impairment and closed store expenses(f)

 

11,753

 

 

3,976

Adjusted EBITDA

$

125,098

 

$

122,792

Adjusted EBITDA, Adjusted Net Income and Adjusted Earnings Per Share Footnotes

(a) 

Consists of acquisition costs as reflected within the consolidated statements of operations, including legal, consulting and other fees, and expenses incurred in connection with acquisitions completed during the applicable period, as well as inventory rationalization expenses incurred in connection with acquisitions. We expect to incur similar costs in connection with other acquisitions in the future and, under GAAP, such costs relating to acquisitions are expensed as incurred and not capitalized.

(b)

Consists of discrete items and project costs, including third-party professional costs associated with strategic transformation initiatives as well as non-recurring payroll-related costs.

(c)  

Includes non-cash amortization expenses relating to cloud computing arrangements.

(d)

Represents non-cash share-based compensation expense.

(e)

Represents foreign currency transaction losses, net that primarily related to the remeasurement of our intercompany loans as well as gains and losses on cross currency swaps and forward contracts.

(f)

Consists of the following items (i) (gains) losses, net on sale leasebacks, disposal of assets, or sale of business; (ii) net losses (gains) on sale for assets held for sale; and (iii) impairment of certain fixed assets and operating lease right-of-use assets related to closed and underperforming locations, lease exit costs and other costs associated with stores that were closed prior to the respective lease termination dates.

(g)

Consists of amortization related to acquired intangible assets as reflected within depreciation and amortization in the consolidated statement of operations.

(h)   

Represents valuation allowances on income tax carryforwards in certain domestic jurisdictions that are not more likely than not to be realized.

(i) 

Represents the tax impact of adjustments associated with the reconciling items between net income (loss) and Adjusted Net Income, excluding the provision for uncertain tax positions and valuation allowance for certain deferred tax assets. To determine the tax impact of the deductible reconciling items, we utilized statutory income tax rates ranging from 9% to 36% depending upon the tax attributes of each adjustment and the applicable jurisdiction.

DRIVEN BRANDS HOLDINGS INC. AND SUBSIDIARIES

ADJUSTED EBITDA RECONCILIATION (UNAUDITED)

 

 

Three Months Ended

(in thousands)

March 29, 2025

 

March 30, 2024

Take 5

$

100,918

 

 

$

88,888

 

Franchise Brands

 

44,383

 

 

 

47,589

 

Car Wash

 

24,388

 

 

 

17,985

 

Corporate and Other

 

(44,591

)

 

 

(31,670

)

Adjusted EBITDA

$

125,098

 

 

$

122,792

 

DRIVEN BRANDS HOLDINGS INC. AND SUBSIDIARIES

ADDITIONAL INFORMATION ON KEY PERFORMANCE INDICATORS (UNAUDITED)

 

 

Three Months Ended March 29, 2025

(in thousands)

Take 5

 

Franchise Brands

 

Car Wash

 

Corporate and Other

 

Total

System-wide Sales

 

 

 

 

 

 

 

 

 

Franchise stores

$

136,688

 

$

1,029,374

 

$

 

$

 

$

1,166,062

Company-operated stores

 

250,800

 

 

3,992

 

 

 

 

59,339

 

 

314,131

Independently operated stores

 

 

 

 

 

66,640

 

 

 

 

66,640

Total System-wide Sales

$

387,488

 

$

1,033,366

 

$

66,640

 

$

59,339

 

$

1,546,833

 

 

 

 

 

 

 

 

 

 

Store Count (in whole numbers)

 

 

 

 

 

 

 

 

 

Franchise stores

 

468

 

 

2,647

 

 

 

 

 

 

3,115

Company-operated stores

 

735

 

 

13

 

 

 

 

216

 

 

964

Independently operated stores

 

 

 

 

 

718

 

 

 

 

718

Total Store Count

 

1,203

 

 

2,660

 

 

718

 

 

216

 

 

4,797

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 30, 2024

(in thousands)

Take 5

 

Franchise Brands

 

Car Wash

 

Corporate and Other

 

Total

System-wide Sales

 

 

 

 

 

 

 

 

 

Franchise stores

$

105,556

 

$

1,070,072

 

$

 

$

 

$

1,175,628

Company-operated stores

 

220,871

 

 

4,469

 

 

 

 

58,889

 

 

284,229

Independently operated stores

 

 

 

 

 

53,047

 

 

 

 

53,047

Total System-wide Sales

$

326,427

 

$

1,074,541

 

$

53,047

 

$

58,889

 

$

1,512,904

 

 

 

 

 

 

 

 

 

 

Store Count (in whole numbers)

 

 

 

 

 

 

 

 

 

Franchise stores

 

374

 

 

2,633

 

 

 

 

 

 

3,007

Company-operated stores

 

661

 

 

14

 

 

 

 

220

 

 

895

Independently operated stores

 

 

 

 

 

718

 

 

 

 

718

Total Store Count

 

1,035

 

 

2,647

 

 

718

 

 

220

 

 

4,620

 

Shareholder/Analyst inquiries:

Dawn Francfort

ICR, Inc.

[email protected]

(203) 682-8200

Media inquiries:

Taylor Blanchard

[email protected]

(704) 644-8129

KEYWORDS: United States North America North Carolina

INDUSTRY KEYWORDS: Aftermarket Retail Automotive Other Automotive Other Retail General Automotive Specialty

MEDIA:

Logo
Logo

Neuronetics Reports First Quarter 2025 Financial and Operating Results

MALVERN, Pa., May 06, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced its financial and operating results for the first quarter of 2025.

First Quarter 2025 Highlights

  • First quarter 2025 revenue of $32.0 million, an 84% increase as compared to the first quarter 2024, primarily driven by the Greenbrook acquisition
  • U.S. clinic revenue of $18.7 million in the quarter representing Greenbrook clinic revenue
  • U.S. treatment session revenue of $9.6 million
  • U.S. NeuroStar Advanced Therapy System revenue of $2.8 million
  • Completed secondary offering, raising approximately $18.9 million in net proceeds in February 2025 after deducting underwriting discounts, commissions and estimated offering expenses

Recent Operational Highlights

  • Chief Financial Officer Steve Furlong to retire in March 2026
  • Significant operational progress with the integration of Greenbrook
  • Projecting cash flow positive in the third quarter of 2025
  • Major insurance coverage expansions for adolescent TMS treatment, with Evernorth Health Services (Cigna) joining Humana, Aetna, and several Blue Cross Blue Shield entities in covering adolescents 15+
  • Achieved milestone of over 202,000 global patients treated with 7.4 million treatment sessions

“2025 is off to a great start as our approach to innovative mental health treatment is improving access to care for patients and delivering value for providers,” said Keith J. Sullivan, President and Chief Executive Officer of Neuronetics. “Our growth initiatives for the Greenbrook clinics continue to exceed expectations, as we implement our proven operating model and continue to rollout SPRAVATO® across our network of locations and institute the buy-and-bill model. Simultaneously, our Better Me Provider program continues to prove its effectiveness, with participating sites continuing to see improvements in the number of patients treated, and the speed at which a patient begins therapy with NeuroStar TMS. As we execute on both fronts, we’re not only expanding access to effective mental health treatments but also strengthening our financial position while remaining on the path to achieving positive cash flow in the third quarter of this year.”

First Quarter 2025 Financial and Operating Results for the Three Months Ended March 31, 2025

                   
    Revenues by Geography      
    Three Months Ended March 31,       
    2025   2024      
       Amount      Amount      % Change  
       
    (Unaudited; in thousands, except percentages)  
U.S.   $ 31,483   $ 16,793   87   %
International     492     624   (21 ) %
Total revenues   $ 31,975   $ 17,417   84   %
                     

Total revenues for the three months ended March 31, 2025 was $32.0 million, an increase of 84% compared to the revenues of $17.4 million in the first quarter of 2024, primarily driven by the Greenbrook acquisition. During the quarter, total U.S. revenue increased by 87% and international revenue decreased marginally over the first quarter of 2024. The increase in U.S. revenue was primarily attributable to U.S. clinic revenue of $18.7 million, added as a result of the acquisition of Greenbrook, partially offset by the absence of prior year quarter sales to Greenbrook of $2.9 million and a decrease of sales of $1.1 million relating to NeuroStar Advanced Therapy Systems and treatment session revenue.

                   
    U.S. Revenues by Product Category      
    Three Months Ended March 31,      
    2025   2024      
    Amount   Amount   % Change  
       
    (Unaudited; in thousands, except percentages)  
NeuroStar Advanced Therapy System   $ 2,846   $ 3,310   (14 ) %
Treatment sessions     9,612     12,988   (26 ) %
Clinic revenue     18,659         %
Other     366     495   (26 ) %
Total U.S. revenues   $ 31,483   $ 16,793   87   %
                     

U.S. NeuroStar Advanced Therapy System revenue for the three months ended March 31, 2025 was $2.8 million, a decrease of 14% compared to $3.3 million in the first quarter of 2024. For the three months ended March 31, 2025, the Company shipped 31 systems. While the number of systems decreased, the average selling price per system increased by 9%.

U.S. treatment session revenue for the three months ended March 31, 2025 was $9.6 million, a decrease of 26% compared to $13.0 million in the first quarter of 2024. The decline was primarily attributable to the absence of $2.8 million in treatment session revenue from Greenbrook with the prior year quarter.

U.S. clinic revenue, which represents revenue generated by treatment centers from the Greenbrook acquisition, was $18.7 million for the three months ended March 31, 2025.

Gross margin for the first quarter of 2025 was 49.2% compared to the first quarter of 2024 gross margin of 75.1%. The decrease in gross margin was primarily a result of the inclusion of Greenbrook’s clinic business.

Operating expenses during the first quarter of 2025 were $26.8 million, an increase of $6.9 million, or 35%, compared to $19.9 million in the first quarter of 2024, mainly attributable to inclusion of Greenbrook’s general and administrative expenses of $6.2 million.

Net loss for the first quarter of 2025 was $(12.7) million, or $(0.21) per share, as compared to $(7.9) million, or $(0.27) per share, in the first quarter of 2024. Net loss per share was based on 61,464,725 and 29,471,516 weighted average common shares outstanding for the first quarters of 2025 and 2024, respectively.

Cash and cash equivalents were $20.2 million as of March 31, 2025. This compares to cash and cash equivalents of $18.5 million as of December 31, 2024. As a result of the strengthened balance sheet following the recent offering, the Company proactively settled Greenbrook’s legacy vendor payment plans and accelerated certain expenses to secure favorable vendor concessions. While this increased first quarter cash burn, it will reduce overall vendor spending in 2025. The Company also experienced a temporary lag in collections during the integration of new revenue cycle management software, which has subsequently normalized. Cash used in operations for the first quarter was $17.0 million. The Company expects second quarter operational cash usage to be less than $5 million, with year-end cash anticipated to be above $20 million.

Chief Financial Officer Steve Furlong to Retire

Steve Furlong, who has served as Chief Financial Officer since 2019, will retire on March 31, 2026. Mr. Furlong will continue in his current position until a successor is hired, and will remain as an advisory subsequently to ensure a smooth transition. The Company has initiated a comprehensive search process to identify his successor.

Expanding Insurance Coverage Increases Adolescent Access to NeuroStar TMS Therapy

Insurance coverage for adolescent NeuroStar transcranial magnetic stimulation (“TMS”) therapy continues to expand since receiving clearance from the U.S. Food and Drug Administration in March 2024 as the first and only TMS treatment approved for depression in adolescents aged 15 to 21. Evernorth Health Services, a wholly owned subsidiary of The Cigna Group, has extended coverage to adolescents 15 and older with major depressive disorder (“MDD”), joining Humana, Aetna, and several Blue Cross Blue Shield entities. This growing payor acceptance reflects the significant clinical need among the estimated 4.3 million U.S. adolescents affected by major depression and positions NeuroStar’s adolescent indication as an important long-term growth driver.

Strategic Financing Strengthens Balance Sheet

Neuronetics successfully completed a public offering of common stock with net proceeds of approximately $18.9 million after deducting underwriting discounts, commissions and estimated offering expenses, strengthening the Company’s financial position and providing additional flexibility to execute on key growth initiatives. This financing enhances the Company’s ability to potentially accelerate high-return programs such as the Spravato buy-and-bill expansion, accelerate Better Me Provider program implementation across the broader network, and enhance capabilities, all while maintaining the Company’s projected timeline to be cash flow positive in the third quarter of 2025.

Business Outlook

For the second quarter of 2025, the Company expects total worldwide revenue between $36.0 million and $38.0 million.

For the full year 2025, the Company now expects total worldwide revenue to be between $149.0 million and $155.0 million, as compared to prior guidance of $145.0 million and $155.0 million.

For the full year 2025, the Company continues to expect gross margin to be approximately 55%.

For the full year 2025, the Company continues to expect total operating expenses to be between $90.0 million and $98.0 million.

The Company expects second quarter operational cash usage to be less than $5.0 million, with year-end cash anticipated to be above $20.0 million.

Webcast and Conference Call Information

Neuronetics’ management team will host a conference call on May 6, 2025, beginning at 8:30 a.m. Eastern Time.

The conference call will be broadcast live in listen-only mode via webcast at https://edge.media-server.com/mmc/p/knieqjnc. To listen to the conference call on your telephone, you may register for the call here. While it is not required, it is recommended you join 10 minutes prior to the event start.

About Neuronetics

Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience, Neuronetics is delivering more treatment options to patients and physicians by offering exceptional in-office treatments that produce extraordinary results. NeuroStar Advanced Therapy (“NeuroStar Therapy”) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication has not helped. In addition to selling the NeuroStar Advanced Therapy System (the “NeuroStar System”) and associated treatment sessions to customers, Neuronetics operates Greenbrook TMS Inc. (“Greenbrook”) treatment centers across the United States, offering NeuroStar Therapy, Spravato, and other treatment modalities for the treatment of MDD and other mental health disorders.

NeuroStar Therapy is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from MDD and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode. It is also cleared by the U.S. Food and Drug Administration as an adjunct for adults with obsessive-compulsive disorder and for adolescent patients aged 15 to 21 with MDD. Neuronetics is committed to transforming lives by offering an exceptional treatment that produces extraordinary results.

“Safe harbor” statement under the Private Securities Litigation Reform Act of 1995:

Certain statements in this press release, including the documents incorporated by reference herein, include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created by those laws and other applicable laws and “forward-looking information” within the meaning of applicable Canadian securities laws. Statements in this press release that are not historical facts constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by terms such as “may,” “will,” “would,” “should,” “expect,” “plan,” “design,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “outlook” or “continue” as well as the negative of these terms and similar expressions. These statements are subject to significant risks and uncertainties and actual results could differ materially from those projected. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. These risks and uncertainties include, without limitation, risks and uncertainties related to: the effect of the transaction with Greenbrook on our business relationships; operating results and business generally; our ability to execute our business strategy; our ability to achieve or sustain profitable operations due to our history of losses; our ability to successfully complete the announced restructuring plans; our reliance on the sale and usage of our NeuroStar Advanced Therapy System to generate revenues; the scale and efficacy of our salesforce; our ability to retain talent; availability of coverage and reimbursement from third-party payors for treatments using our products; physician and patient demand for treatments using our products; developments in respect of competing technologies and therapies for the indications that our products treat; product defects; our revenue has been concentrated among a small number of customers; our ability to obtain and maintain intellectual property protection for our technology; developments in clinical trials or regulatory review of the NeuroStar Advanced Therapy System for additional indications; developments in regulation in the U.S. and other applicable jurisdictions; the terms of our credit facility; our ability to successfully roll-out our Better Me Provider Program on the planned timeline; our self-sustainability and existing cash balances; and our ability to achieve cash flow breakeven in the third quarter of 2025. For a discussion of these and other related risks, please refer to the Company’s recent filings with the SEC, which are available on the SEC’s website at www.sec.gov. These forward-looking statements are based on the Company’s expectations and assumptions as of the date of this press release. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events, or changes in the Company’s expectations.

Investor Contact:

Mike Vallie or Mark Klausner
ICR Healthcare
443-213-0499
[email protected] 

Media Contact:

EvolveMKD
646-517-4220
[email protected] 

NEURONETICS, INC.

Consolidated Statements of Operations

(Unaudited; In thousands, except per share data)
    Three Months ended
    March 31,
    2025     2024  
Revenues   $ 31,975     $ 17,417  
Cost of revenues     16,237       4,329  
Gross profit     15,738       13,088  
Operating expenses:            
Sales and marketing     11,999       11,641  
General and administrative     13,137       5,957  
Research and development     1,616       2,349  
Total operating expenses     26,752       19,947  
Loss from operations     (11,014 )     (6,859 )
Other (income) expense:            
Interest expense     1,922       1,826  
Other income, net     (247 )     (812 )
Net loss   $ (12,689 )   $ (7,873 )
Non-controlling interest     (14 )      
Net loss attributable to Neuronetics stockholders’     (12,675 )     (7,873 )
Net loss per share of common stock outstanding, basic and diluted attributable to Neuronetics stockholders’   $ (0.21 )   $ (0.27 )
Weighted average common shares outstanding, basic and diluted     61,465       29,472  
                 

NEURONETICS, INC.

Consolidated Balance Sheets

(Unaudited; In thousands, except per share data)
 
    March 31,   December 31,
    2025     2024  

Assets
           
Current assets:            
Cash and cash equivalents   $ 20,224     $ 18,459  
Restricted cash     1,000       1,000  
Accounts receivable, net of allowance of credit losses of $1,403 and $1,930 as of March 31, 2025 and December 31, 2024, respectively     26,196       23,355  
Inventory     4,069       4,248  
Current portion of net investments in sales-type leases     202       206  
Current portion of prepaid commission expense     3,113       3,078  
Current portion of note receivables     696       930  
Prepaid expenses and other current assets     5,168       6,846  
Total current assets     60,668       58,122  
Property and equipment, net     5,846       6,242  
Goodwill     18,634       18,634  
Intangible assets, net     19,242       19,606  
Operating lease right-of-use assets     26,704       27,093  
Net investments in sales-type leases     74       86  
Prepaid commission expense     8,466       8,902  
Long-term notes receivable     316       295  
Other assets     2,038       1,923  
Total assets   $ 141,988     $ 140,903  

Liabilities and Equity
           
Current liabilities:            
Accounts payable   $ 8,482     $ 11,077  
Accrued expenses     9,306       12,818  
Current portion of deferred revenue     785       974  
Deferred and contingent consideration     1,000       1,000  
Other payables     346       605  
Current portion of operating lease liabilities     4,922       4,791  
Total current liabilities     24,841       31,265  
Long-term debt, net     55,341       55,151  
Deferred revenue           2  
Operating lease liabilities     22,275       22,686  
Total liabilities     102,457       109,104  
Commitments and contingencies            
Equity:            
Preferred stock, $0.01 par value: 10,000 shares authorized; no shares issued or outstanding on March 31, 2025 and December 31, 2024            
Common stock, $0.01 par value: 250,000 shares authorized; 65,820 and 55,679 shares issued and outstanding on March 31, 2025 and December 31, 2024, respectively     658       557  
Additional paid-in capital     467,258       446,938  
Accumulated deficit     (432,464 )     (419,789 )
Total Stockholders’ equity     35,452       27,706  
Non-controlling interest     4,079       4,093  
Total equity     39,531       31,799  
Total liabilities and equity   $ 141,988     $ 140,903  
                 

NEURONETICS, INC.

Consolidated Statements of Cash Flows

(Unaudited; In thousands)
 
    Three months ended March 31,
    2025     2024  
Cash flows from Operating activities:            
Net loss   $ (12,689 )   $ (7,873 )
Adjustments to reconcile net loss to net cash used in operating activities:            
Depreciation and amortization     911       560  
Allowance for credit losses           566  
Inventory impairment     5       71  
Share-based compensation     1,444       1,338  
Non-cash interest expense     189       161  
Changes in certain assets and liabilities:            
Accounts receivable, net     (2,627 )     (2,667 )
Inventory     175       1,328  
Net investment in sales-type leases     14       234  
Prepaid commission expense     401       (154 )
Prepaid expenses and other assets     1,785       116  
Accounts payable     (2,638 )     (1,983 )
Accrued expenses     (3,511 )     (3,549 )
Other liabilities     (193 )      
Deferred revenue     (259 )     (163 )
Net Cash used in Operating activities     (16,993 )     (12,015 )
             
Cash flows from Investing activities:            
Purchases of property and equipment and capitalized software     (219 )     (375 )
Repayment of notes receivable           443  
Net Cash (used in) provided by Investing activities     (219 )     68  
             
Cash flows from Financing activities:            
Proceeds from the issuance of common stock     20,700        
Payments of common stock offering issuance costs     (1,731 )      
Proceeds from exercises of stock options     8        
Net Cash provided by Financing activities     18,977        
Net increase (decrease) in Cash, Cash equivalents and Restricted cash     1,765       (11,947 )
Cash, Cash equivalents and Restricted cash, Beginning of Period     19,459       59,677  
Cash, Cash equivalents and Restricted cash, End of Period   $ 21,224     $ 47,730  
             
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet:            
Cash and cash equivalents     20,224       47,730  
Restricted cash     1,000        
Total cash, cash equivalents and restricted cash   $ 21,224     $ 47,730  
                 


Non-GAAP Financial Measures (Unaudited)

EBITDA is not a measure of financial performance under generally accepted accounting principles in the U.S. (“GAAP”), and should not be construed as a substitute for, or superior to, GAAP net loss. However, management uses both the GAAP and non-GAAP financial measures internally to evaluate and manage the Company’s operations and to better understand its business. Further, management believes that the addition of the non-GAAP financial measure provides meaningful supplementary information to, and facilitates analysis by, investors in evaluating the Company’s financial performance, results of operations and trends. The Company’s calculation of EBITDA may not be comparable to similarly designated measures reported by other companies, because companies and investors may differ as to what type of events warrant adjustment.

The following table reconciles reported net loss to EBITDA:

             
    Three Months ended
    March 31,
    2025     2024  
     
    (in thousands)
Net loss   $ (12,689 )   $ (7,873 )
Interest expense, net     1,675       1,014  
Income taxes            
Depreciation and amortization     911       560  
EBITDA   $ (10,103 )   $ (6,299 )
                 



REGENXBIO to Participate in Upcoming Investor Conferences

PR Newswire


ROCKVILLE, Md.
, May 6, 2025 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences:

BofA Securities Health Care Conference 2025

Presentation: 

Tuesday, May 13, 2025 at 5:00 p.m. PT

Location: 

Las Vegas, NV

RBC Global Healthcare Conference

Fireside Chat:

Tuesday, May 20, 2025 at 11:30 a.m. ET

Location:
New York, NY

H.C. Wainwright BioConnect

Fireside Chat:

Tuesday, May 20, 2025 at 4:00 p.m. ET

Location:
New York, NY

Stifel Virtual Ophthalmology Forum 

Fireside Chat:
Tuesday, May 27, 2025 at 9:30 a.m. ET
Location: Virtual

UBS Spring Biotech Conference

1×1 Investor Meetings:
Tuesday, June 24, 2025

Location:
New York, NY

Live webcasts of select presentations and fireside chats can be accessed in the Investors section of REGENXBIO’s website at www.regenxbio.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.

ABOUT REGENXBIO Inc.
REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; clemidsogene lanparvovec (RGX-121) for the treatment of MPS II and RGX-111 for the treatment of MPS I, both in partnership with Nippon Shinyaku; and surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic retinopathy, in collaboration with AbbVie. Thousands of patients have been treated with REGENXBIO’s AAV platform, including those receiving NovartisZOLGENSMA®. REGENXBIO’s investigational gene therapies have the potential to change the way healthcare is delivered for millions of people. For more information, please visit WWW.REGENXBIO.COM.

Contacts:

Dana Cormack

Corporate Communications
[email protected] 

Investors:
George E. MacDougall
Investor Relations
[email protected]

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-302446818.html

SOURCE REGENXBIO Inc.

The Joint Corp. Strengthens Management Appointing SVP Legal and SVP Operations and Patient Experience

– Franchising legal specialist Andra J. Terrell with 20 years of experience in global master, single-unit and multi-unit franchising; compliance strategy; and financing, mergers, acquisitions, and divestitures-

– Franchise operations leader Eric Wyatt with over 30 years of experience to improve clinic economics, enhance the patient experience, and reignite growth –

SCOTTSDALE, Ariz., May 06, 2025 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network, welcomes new executives to help execute plan to strengthen the company core, reignite growth, and improve clinic and company level profitability. Both will report to President and CEO Sanjiv Razdan.

  • Andra J. Terrell, Senior Vice President Legal, undertakes this newly created role to advance legal execution for the franchise system.
  • Eric Wyatt, Senior Vice President Operations and Patient Experience, is tasked to oversee clinic operations, improve quality and economics of our clinics, and elevate the patient experience.

Andra J. Terrell: Elevating Legal Structure at The Joint

“Andra is an innovative franchising legal specialist with proven expertise in global master, single-unit and multi-unit franchising, expansion and compliance strategy, complex transactions, multi-billion dollar financing and mergers, acquisitions and divestitures,” said Razdan. “Committed to our growth as a pure-play franchisor, we created the SVP Legal role. Andra is exceptionally qualified to establish our internal legal department, having significant experience in legal operations, legal department modernization, and intellectual property portfolio management.”

Terrell said, “I have spent two decades managing legal matters for numerous franchise systems. The Joint recently outlined a multi-phased, multi-year approach to become America’s most accessible health and wellness services company. I am excited to join the team to help execute our vision.”

Terrell most recently served as Senior Assistant General Counsel at Franchise World Headquarters (Subway), where she closed the sale of Subway to Roark Capital, the largest whole business securitization on record and a significant refinancing. Prior, she served as SVP, GC and Corporate Secretary at Regis Corporation, and as VP, Deputy GC and Assistant Secretary at Cajun Operating Company. While Assistant GC at Luxottica Retail North America, Terrell was part of the team that implemented nationwide managed vision care agreement as well as new Pearle Vision Full Service Program. Other legal roles were at GNC Franchising and Decorating Den Systems.

Terrell holds a Bachelor of Science in Natural Sciences and History of Science from John Hopkins University and a Juris Doctor from Howard University School of Law. A prolific author, Terrell has published multiple legal handbooks, papers and articles.

Eric Wyatt: Bringing Franchise Operations Expertise for Nationally Recognized Brands

“Eric is a dynamic and collaborative leader with 30 years of executive leadership experience in franchise operations, general management, and strategic planning,” added Razdan. “Eric’s ability to drive performance, build strong teams, and enhance franchise relationships will be invaluable. We are thrilled to welcome him to our team.”

Wyatt said, “I am honored to join The Joint at such a pivotal time. The company’s innovative approach to healthcare and commitment to improving lives aligns with my passion for building brands that make a difference. I look forward to collaborating with the team to accelerate expansion and deliver value to our franchisees, patients, and stakeholders.”

Wyatt most recently served as CEO of Clean Eatz LLC, overseeing a franchise organization with over 100 locations in 23 states and multiple revenue streams. Prior, he was President & CEO of Norms Restaurant LLC, a Southern California-based diner chain with more than $150 million in annual revenue. Wyatt also held senior leadership roles at CKE Restaurants as SVP of Operations for the Hardee’s brand, and CEO and COO at Boston Market Corporation, where he led transformational change and operational excellence initiatives across hundreds of locations. Wyatt’s earlier experience includes executive roles at Panera Bread, L Brands, and Starbucks Corporation. He began his career in franchise and company operations at Taco Bell and Mobil Oil.

Wyatt holds a Bachelor of Arts in Speech Communications from East Stroudsburg University and serves on the Board of Directors for the East Stroudsburg University Foundation.

About The Joint Corp. (NASDAQ: JYNT)

The Joint Corp. (NASDAQ: JYNT) revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, it is the nation’s largest operator, manager and franchisor of chiropractic clinics through The Joint Chiropractic network. The company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. Headquartered in Scottsdale, with over 950 locations nationwide and more than 14 million patient visits annually, The Joint Chiropractic is a key leader in the chiropractic industry. The brand is consistently named to Franchise Times’ annual “Top 400” and “Fast & Serious” list of 40 smartest growing brands. Entrepreneur named The Joint “No. 1 in Chiropractic Services,” and is regularly ranked on the publication’s “Franchise 500,” the “Fastest-Growing Franchises,” the “Best of the Best” lists, as well as its “Top Franchise for Veterans” and “Top Brands for Multi-Unit Owners.” SUCCESS named the company as one of the “Top 50 Franchises” in 2024. The Joint Chiropractic is an innovative force, where healthcare meets retail. For more information, visit www.thejoint.com. To learn about franchise opportunities, visit www.thejointfranchise.com.

Business Structure

The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Washington, and West Virginia, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices.

Media Contact:

Margie Wojciechowski, The Joint Corp., [email protected]  

Investor Contact:

Kirsten Chapman, Alliance Advisors IR, 415-433-3777, [email protected]

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/6050b957-f24f-4266-ab62-85b8131336cf

https://www.globenewswire.com/NewsRoom/AttachmentNg/73e58579-d9bb-4cc2-a0e7-19e6ddbc3f06